{"nct_id":"NCT05134948","title":"A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-11-30","start_date_type":"ACTUAL","primary_completion_date":"2025-10-22","primary_completion_date_type":"ESTIMATED","completion_date":"2025-10-22","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}